微信公众号:蹊之美股生物医药 / CaesarBiotech
Gainers:
NeuroMetrix (NASDAQ:NURO) +65%
Reneo Pharmaceuticals (NASDAQ:RPHM) +25%
Neoleukin Therapeutics (NASDAQ:NLTX) +23%
InspireMD (NASDAQ:NSPR) +16%
Chembio Diagnostics (N...查看全文
$InspireMD(NSPR)$ 3 Initial statement of beneficial ownership of securities Accession Number: 0001493152-23-006395 Size: 2 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-22-030876 Act: 34 Size: 312 KB 网页链接
$InspireMD(NSPR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-22-030818 Act: 34 Size: 3 MB 网页链接
$InspireMD(NSPR)$ 8-K Current report, item 5.07 Accession Number: 0001493152-22-024842 Act: 34 Size: 212 KB 网页链接
$InspireMD(NSPR)$ 4 Statement of changes in beneficial ownership of securities Accession Number: 0001493152-22-023735 Size: 5 KB 网页链接
$InspireMD(NSPR)$ 8-K Current report, items 2.02 and 9.01 Accession Number: 0001493152-22-022086 Act: 34 Size: 418 KB 网页链接
$InspireMD(NSPR)$ 10-Q Quarterly report [Sections 13 or 15(d)] Accession Number: 0001493152-22-021613 Act: 34 Size: 3 MB 网页链接
$InspireMD(NSPR)$ DEFA14A Additional definitive proxy soliciting materials and Rule 14(a)(12) material Accession Number: 0001493152-22-018548 Act: 34 Size: 807 KB 网页链接
$InspireMD(NSPR)$ DEF 14A Other definitive proxy statements Accession Number: 0001493152-22-018544 Act: 34 Size: 2 MB 网页链接
$InspireMD(NSPR)$ EFFECT Notice of Effectiveness Accession Number: 9999999995-22-001786 Act: 33 Size: 1 KB 网页链接